BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Ligand Reports First Quarter 2023 Financial Results

  Ligand Pharmaceuticals Incorporated reported financial results for the three months ended March 31, 2023, and provided an operating forecast and business updates.

  May 4, 2023

   · 

  23 min read
• Biotech Bay

  4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock - May 04, 2023

  4D Molecular Therapeutics, Inc., a clinical-stage biotherapeutics company harnessing the power of directed evolution for genetic medicines targeting large market diseases, announced that it has commenced an underwritten public offering of $100.0 million of shares of its common stock.

  May 4, 2023

   · 

  5 min read
• Biotech Bay

  SI-BONE Announces Launch of Public Offering of Common Stock - May 04, 2023

  SI-BONE, Inc., a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced that it has commenced an underwritten public offering of 3,775,000 shares of its common stock.

  May 4, 2023

   · 

  3 min read
• Business

  Cardiff Oncology Reports First-Quarter 2023 Results and Provides Business Update

  Cardiff Oncology, Inc. announced financial results for the first-quarter ended March 31, 2023, and provided a business update.

  May 4, 2023

   · 

  9 min read
• Business

  SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

  SenesTech, Inc. will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023.

  May 4, 2023

   · 

  3 min read
• Business

  Nuvation Bio Reports First Quarter 2023 Financial Results and Provides Business Update

  Nuvation Bio Inc., a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates, reported its financial results for the first quarter ended March 31, 2023, and provided a business update.

  May 4, 2023

   · 

  7 min read
• Business

  AbCellera Reports Q1 2023 Business Results

  AbCellera announced financial results for the first quarter of 2023. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

  May 4, 2023

   · 

  13 min read
• Business

  Paragon 28 Reports First Quarter 2023 Financial Results and Reaffirms 2023 Net Revenue Guidance

  Paragon 28, Inc., a leading medical device company exclusively focused on the foot and ankle orthopedic market, reported financial results for the quarter ended March 31, 2023 and reaffirmed its 2023 net revenue guidance.

  May 4, 2023

   · 

  12 min read
• Biotech Beach

  Pipeline Therapeutics to Present at the 2023 RBC Global Healthcare Conference

  Pipeline Therapeutics announced that Carmine Stengone, CEO of Pipeline, will present on Tuesday, May 16, 2023 at 4:05 pm ET at the RBC Global Healthcare Conference, being held May 16-17, 2023 in New York, NY.

  May 4, 2023

   · 

  1 min read
• Business

  DBV Technologies Reports First Quarter 2023 Financial Results

  DBV Technologies, a clinical-stage biopharmaceutical company, reported financial results for the first quarter of 2023.

  May 4, 2023

   · 

  6 min read